A detailed history of Baldwin Brothers LLC transactions in Organon & Co. stock. As of the latest transaction made, Baldwin Brothers LLC holds 475 shares of OGN stock, worth $7,153. This represents 0.0% of its overall portfolio holdings.

Number of Shares
475
Previous 475 -0.0%
Holding current value
$7,153
Previous $9,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 12, 2024

SELL
$13.78 - $18.8 $1,515 - $2,068
-110 Reduced 18.8%
475 $8,000
Q4 2023

Jan 08, 2024

SELL
$10.95 - $17.32 $5,573 - $8,815
-509 Reduced 46.53%
585 $8,000
Q3 2023

Oct 10, 2023

SELL
$16.59 - $23.77 $1,708 - $2,448
-103 Reduced 8.6%
1,094 $18,000
Q2 2023

Jul 14, 2023

SELL
$19.27 - $24.63 $3,487 - $4,458
-181 Reduced 13.13%
1,197 $24,000
Q1 2023

Apr 21, 2023

SELL
$21.42 - $32.08 $4,412 - $6,608
-206 Reduced 13.01%
1,378 $32,000
Q4 2022

Jan 27, 2023

BUY
$23.31 - $28.61 $2,027 - $2,489
87 Added 5.81%
1,584 $0
Q3 2022

Oct 14, 2022

SELL
$23.4 - $34.25 $5,077 - $7,432
-217 Reduced 12.66%
1,497 $35,000
Q2 2022

Jul 18, 2022

BUY
$31.66 - $38.9 $54,265 - $66,674
1,714 New
1,714 $58,000
Q1 2022

Apr 13, 2022

SELL
$30.45 - $39.36 $189,916 - $245,488
-6,237 Closed
0 $0
Q4 2021

Jan 14, 2022

SELL
$28.67 - $37.13 $168,464 - $218,175
-5,876 Reduced 48.51%
6,237 $190,000
Q3 2021

Oct 27, 2021

SELL
$28.63 - $35.64 $176,303 - $219,471
-6,158 Reduced 33.7%
12,113 $397,000
Q2 2021

Jul 30, 2021

BUY
$28.45 - $38.0 $519,809 - $694,298
18,271 New
18,271 $553,000

Others Institutions Holding OGN

About Organon & Co.


  • Ticker OGN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 254,330,000
  • Market Cap $3.83B
  • Description
  • Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...
More about OGN
Track This Portfolio

Track Baldwin Brothers LLC Portfolio

Follow Baldwin Brothers LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Baldwin Brothers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Baldwin Brothers LLC with notifications on news.